Endocrine changes in histiocytosis of the hypothalamic-pituitary axis

被引：7

作者：

Toro Galvan, Silvia ^{[1
]}

Planas Vilaseca, Alejandra ^{[1
]}

Michalopoulou Alevras, Theodora ^{[1
]}

Torres Diaz, Alberto ^{[2
]}

Suarez Balaguer, Javier ^{[1
]}

Villabona Artero, Carles ^{[1
]}

机构：

[1] Hosp Univ Bellvitge, Hosp Llobregat, Serv Endocrinol & Nutr, Barcelona, Spain

[2] Hosp Univ Bellvitge, Hosp Llobregat, Serv Neurocirug, Barcelona, Spain

来源：

ENDOCRINOLOGIA Y NUTRICION | 2015年 / 62卷 / 02期

关键词：

Langerhans cell histiocytosis; Chester-Erdheim disease; Diabetes insipidus; Hypopituitarism; LANGERHANS CELL HISTIOCYTOSIS; ERDHEIM-CHESTER DISEASE; DIABETES-INSIPIDUS; PERMANENT CONSEQUENCES; ADULT PATIENTS; MANAGEMENT; HYPOPITUITARISM; GUIDELINES; DIAGNOSIS; CHILDREN;

D O I：

10.1016/j.endonu.2014.10.004

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Histiocytosis is characterized by proliferation of cells from the mononuclear phagocyte system, and may be divided into Langerhans cell histiocytosis (LCH) and non-Langerhans cell histiocytosis (including Erdheim-Chester disease [ECD]). While diabetes insipidus (DI) is the most common hypothalamic-pituitary consequence, anterior pituitary deficiencies are less known. This study analyzed the frequency and progression of pituitary hormone deficiencies and the radiographic findings in 9 patients (7 with LCH and 2 with ECD) with hypothalamic-pituitary (HP) axis. Eighty-nine percent of patients had DI (62% at diagnosis), and 78% had one or more anterior pituitary deficiencies (71% at diagnosis). HP involvement is relatively common in patients diagnosed with histiocytosis and hormone deficiencies may be present at diagnosis or appear gradually during the course of disease. Regular monitoring of these patients is recommended. (C) 2014 SEEN. Published by Elsevier Espana, S.L.U. All rights reserved.

引用

页码：72 / 79

页数：8

共 29 条

[1] Langerhans cell histiocytosis in adults report from the International Registry of the Histiocyte Society [J].

Aricò, M ;

Girschikofsky, M ;

Généreau, T ;

Klersy, C ;

McClain, K ;

Grois, N ;

Emile, JF ;

Lukina, E ;

De Juli, E ;

Danesino, C .

EUROPEAN JOURNAL OF CANCER, 2003, 39 (16) :2341-2348

[2] Pulmonary Involvement in Erdheim-Chester Disease A single-center study of thirty-four patients and a review of the literature [J].

Arnaud, Laurent ;

Pierre, Isabelle ;

Beigelman-Aubry, Catherine ;

Capron, Frederique ;

Brun, Anne-Laure ;

Rigolet, Aude ;

Girerd, Xavier ;

Weber, Nina ;

Piette, Jean-Charles ;

Grenier, Philippe A. ;

Amoura, Zahir ;

Haroche, Julien .

ARTHRITIS AND RHEUMATISM, 2010, 62 (11) :3504-3512

[3]

AXIOTIS CA, 1991, CANCER-AM CANCER SOC, V67, P1650, DOI 10.1002/1097-0142(19910315)67:6<1650::AID-CNCR2820670629>3.0.CO

[4]

2-T

[5]

BROADBENT V, 1994, BRIT J CANCER, V70, pS11

[6] Current therapy for Langerhans cell histiocytosis [J].

Broadbent, V ;

Gadner, H .

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1998, 12 (02) :327-+

[7] Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease [J].

Diamond, Eli L. ;

Dagna, Lorenzo ;

Hyman, David M. ;

Cavalli, Giulio ;

Janku, Filip ;

Estrada-Veras, Juvianee ;

Ferrarini, Marina ;

Abdel-Wahab, Omar ;

Heaney, Mark L. ;

Scheel, Paul J. ;

Feeley, Nancy K. ;

Ferrero, Elisabetta ;

McClain, Kenneth L. ;

Vaglio, Augusto ;

Colby, Thomas ;

Arnaud, Laurent ;

Haroche, Julien .

BLOOD, 2014, 124 (04) :483-492

[8]

Donadieu J, 1996, ARCH DIS CHILD, V75, P17

[9]

FAVARA BE, 1987, LANCET, V1, P208

[10] Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net [J].

Girschikofsky, Michael ;

Arico, Maurizio ;

Castillo, Diego ;

Chu, Anthony ;

Doberauer, Claus ;

Fichter, Joachim ;

Haroche, Julien ;

Kaltsas, Gregory A. ;

Makras, Polyzois ;

Marzano, Angelo V. ;

de Menthon, Mathilde ;

Micke, Oliver ;

Passoni, Emanuela ;

Seegenschmiedt, Heinrich M. ;

Tazi, Abdellatif ;

McClain, Kenneth L. .

ORPHANET JOURNAL OF RARE DISEASES, 2013, 8

← 1 2 3 →